CN1134279A - 舍曲林在治疗癌症病人中的用途 - Google Patents

舍曲林在治疗癌症病人中的用途 Download PDF

Info

Publication number
CN1134279A
CN1134279A CN96100656A CN96100656A CN1134279A CN 1134279 A CN1134279 A CN 1134279A CN 96100656 A CN96100656 A CN 96100656A CN 96100656 A CN96100656 A CN 96100656A CN 1134279 A CN1134279 A CN 1134279A
Authority
CN
China
Prior art keywords
sertraline
cancer
treatment
patient
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96100656A
Other languages
English (en)
Chinese (zh)
Inventor
皮埃尔·E·埃泰纳
克劳格·萨克斯顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1134279A publication Critical patent/CN1134279A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN96100656A 1995-01-17 1996-01-16 舍曲林在治疗癌症病人中的用途 Pending CN1134279A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37314895A 1995-01-17 1995-01-17
US373,148 1995-01-17

Publications (1)

Publication Number Publication Date
CN1134279A true CN1134279A (zh) 1996-10-30

Family

ID=23471181

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96100656A Pending CN1134279A (zh) 1995-01-17 1996-01-16 舍曲林在治疗癌症病人中的用途

Country Status (9)

Country Link
EP (1) EP0727206A2 (2)
JP (1) JPH0925230A (2)
KR (1) KR960028907A (2)
CN (1) CN1134279A (2)
AU (2) AU2265695A (2)
CA (1) CA2167257C (2)
IL (1) IL116733A (2)
WO (1) WO1996022085A1 (2)
ZA (1) ZA96314B (2)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109330998A (zh) * 2018-09-19 2019-02-15 天津科技大学 一种胺盐酸盐化合物的新用途
CN112661657A (zh) * 2021-01-07 2021-04-16 中国人民解放军陆军军医大学 一种舍曲林侧链氨基结构衍生物及其制备方法和应用
CN117017990A (zh) * 2023-08-28 2023-11-10 温州医科大学 厄达替尼联用度洛西汀或舍曲林在制备治疗肿瘤的药物中的应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT409084B (de) * 2000-07-13 2002-05-27 Ledochowski Maximilian Dr Antimykotisch wirkendes arzneimittel
GB0202337D0 (en) * 2002-02-01 2002-03-20 Univ Birmingham Cancer treatment
FR2849382A1 (fr) * 2002-12-26 2004-07-02 Urogene Utilisation du gene htr2b pour le traitement du cancer de la prostate
EP1656124A1 (en) * 2003-03-12 2006-05-17 Cerenis Methods and compositions for the treatment of cancer
US20060009506A1 (en) * 2004-07-09 2006-01-12 Odyssey Thera, Inc. Drugs for the treatment of neoplastic disorders
FR2888506A1 (fr) * 2005-07-12 2007-01-19 Cerenis Sa Utilisation de la 4-(3,4-dichloro-phenyl)-1,2,3,4- tetrahydro-naphtalen-1-ylamine pour le traitement du cancer
SG176571A1 (en) * 2009-05-19 2012-01-30 Vivia Biotech Sl Methods for providing personalized medicine tests ex vivo for hematological neoplasms

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596807A (en) * 1985-03-26 1986-06-24 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109330998A (zh) * 2018-09-19 2019-02-15 天津科技大学 一种胺盐酸盐化合物的新用途
CN112661657A (zh) * 2021-01-07 2021-04-16 中国人民解放军陆军军医大学 一种舍曲林侧链氨基结构衍生物及其制备方法和应用
CN117017990A (zh) * 2023-08-28 2023-11-10 温州医科大学 厄达替尼联用度洛西汀或舍曲林在制备治疗肿瘤的药物中的应用

Also Published As

Publication number Publication date
KR960028907A (ko) 1996-08-17
JPH0925230A (ja) 1997-01-28
IL116733A (en) 2000-09-28
EP0727206A2 (en) 1996-08-21
WO1996022085A1 (en) 1996-07-25
IL116733A0 (en) 1996-05-14
EP0727206A3 (2) 1996-08-28
AU2265695A (en) 1996-08-07
CA2167257A1 (en) 1996-07-18
CA2167257C (en) 1999-09-07
AU4202096A (en) 1996-07-25
ZA96314B (en) 1997-07-16

Similar Documents

Publication Publication Date Title
TWI314053B (en) Use of compounds that are effective as selective opiate receptor modulators
CN1188120C (zh) 治疗饮食紊乱的方法
KR102472588B1 (ko) 니트라이트의 약제학적 제형 및 이의 용도
TW536402B (en) Pharmaceutical composition for the therapy of voiding dysfunction
CN1134279A (zh) 舍曲林在治疗癌症病人中的用途
EP1039900B1 (en) Pharmaceutical composition containing sibutramine and orlistat
JPH11507051A (ja) 骨損失を最少にする方法
US6376552B1 (en) Treatment of gallstones
CN1161114C (zh) 一种治疗睡眠障碍的化合物在制药中的用途
CN1147937A (zh) 利用舍曲林来治疗心肌梗塞后的病人
SK18242001A3 (sk) Terapeutické prípravky na báze sibutramínu vrátane jeho enantiomérov a farmaceuticky prijateľných solí a orlistatu a ich použitie
EP4420721A2 (en) Methods of contraception using nomegestrol acetate and estradiol
AU773490B2 (en) Treatment of osteoarthritis
HUT76855A (en) Use of benzotiophene derivatives for production pharmaceutical compositions useful for bone healing and fracture repair
WO2025026307A1 (zh) 吡啶酮甲酰胺化合物治疗i型神经纤维瘤相关疾病的用途
Doyle First-in-Class Antibody-Drug Conjugate Effective in HER2-Negative Metastatic Breast Cancer.
JPH10504579A (ja) 原発性子宮内膜過形成の抑制法
JP2002539252A (ja) 胆石の治療
JPH11116471A (ja) 乳癌の予防のためのドロロキシフェン

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication